Clinicopathologic features and treatment outcomes in malignant lymphoma of pediatric and young adult patients in Korea: Comparison of Korean all-ages group and Western younger age group
- Authors
- Hwang, IG[Hwang, In Gyu]; Yoo, KH[Yoo, Keon Hee]; Lee, SH[Lee, Soo Hyun]; Park, YH[Park, Yeon Hee]; Lim, TK[Lim, Tae Kyu]; Lee, SC[Lee, Sang Cheol]; Park, S[Park, Sara]; Park, BB[Park, Byeong -Bae]; Ko, YH[Ko, Young Hyeh]; Kim, K[Kim, Kihyun]; Koo, HH[Koo, Hong Hoe]; Kim, WS[Kim, Won Seog]
- Issue Date
- Nov-2007
- Publisher
- CIG MEDIA GROUP, LP
- Keywords
- bone marrow; non-Hodgkin lymphoma; radiation therapy
- Citation
- CLINICAL LYMPHOMA & MYELOMA, v.7, no.9, pp.580 - 586
- Indexed
- SCIE
SCOPUS
- Journal Title
- CLINICAL LYMPHOMA & MYELOMA
- Volume
- 7
- Number
- 9
- Start Page
- 580
- End Page
- 586
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/83712
- DOI
- 10.3816/CLM.2007.n.044
- ISSN
- 1557-9190
- Abstract
- Purpose: The aim of this study is to define distinctive clinicopathologic features of malignant lymphoma in pediatric and young adult patients, particularly in Korea. Patients and Methods: From May 1993 to November 2005, 294 pediatric and young adult patients (age range, 0-31 years) with malignant lymphoma were analyzed in this study at Samsung Medical Center. We also compared this group with the Korean all-ages group and Western younger age group using previously reported data. Results: Hodgkin disease appears more common in the younger age group than in the all-ages group (15% vs. 5.3%; P = .001). Among patients with non-Hodgkin lymphoma (NHL), T/natural killer cell immunophenotype is more common in the present younger age group than the all-ages group (45.5% vs. 25%; P = .001) and Western younger age group (45.5% vs. 13.3%; P = .001). Lymphoblastic lymphoma and T-anaplastic large-cell lymphoma included relatively higher proportions in the younger age group. Overall survival for patients in the group aged 21-31 years was significantly inferior to that of the other younger age group (P = .014). Conclusion: The incidence of Hodgkin disease and T-cell NHL is relatively higher in pediatric and young-adult population group than the all-ages group. However, treatment outcome of the younger age group, excluding lymphoblastic lymphoma, seems to be similar to those in any age group.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/83712)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.